Edition:
United Kingdom

Genocea Biosciences Inc (GNCA.OQ)

GNCA.OQ on NASDAQ Stock Exchange Global Market

0.88USD
22 Jan 2018
Change (% chg)

$-0.01 (-1.21%)
Prev Close
$0.89
Open
$0.90
Day's High
$0.91
Day's Low
$0.86
Volume
315,950
Avg. Vol
182,761
52-wk High
$7.28
52-wk Low
$0.79

Chart for

About

Genocea Biosciences, Inc., is harnessing the power of T cell immunity to develop vaccines and immunotherapies company. The Company uses its discovery platform, AnTigen Lead Acquisition System (ATLAS), to design vaccines and immunotherapies that act, in part, through T cell (or cellular) immune responses. The Company has one... (more)

Overall

Beta: 2.01
Market Cap(Mil.): $50.18
Shares Outstanding(Mil.): 28.67
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 85.70 16.58
EPS (TTM): -- -- --
ROI: -- 3.19 10.60
ROE: -- 4.52 14.19

BRIEF-Genocea Biosciences, Inc. Announces Pricing Of $55 Mln Concurrent Public Offerings

* GENOCEA BIOSCIENCES, INC. ANNOUNCES PRICING OF $55 MILLION CONCURRENT PUBLIC OFFERINGS

17 Jan 2018

BRIEF-Genocea Biosciences Announces Proposed Concurrent Public Offerings Of Common Stock

* GENOCEA BIOSCIENCES, INC. ANNOUNCES PROPOSED CONCURRENT PUBLIC OFFERINGS OF COMMON STOCK AND CLASS A WARRANTS AND SERIES A CONVERTIBLE PREFERRED STOCK AND CLASS A WARRANTS

16 Jan 2018

BRIEF-Genocea Biosciences inc qtrly ‍loss per share $0.59​

* Genocea biosciences - ‍expects existing cash and cash equivalents sufficient to support operating expenses and capital expenditure into middle of 2018​

02 Nov 2017

BRIEF-Genocea announces strategic shift to immuno-oncology and the development of neoantigen cancer vaccines

* Genocea announces strategic shift to immuno-oncology and the development of neoantigen cancer vaccines

25 Sep 2017

BRIEF-Genocea Biosciences reports qtrly loss per share $‍0.54​

* Genocea Biosciences reports second quarter 2017 financial results

09 Aug 2017

Competitors

  Price Chg
Novartis AG (NOVN.S) CHF83.46 +0.08
Pfizer Inc. (PFE.N) $36.78 -0.17
Merck & Co., Inc. (MRK.N) $61.13 -0.15
Sanofi SA (SASY.PA) €70.83 -2.12
AstraZeneca plc (AZN.L) 5,054.00 +11.00
GlaxoSmithKline plc (GSK.L) 1,355.20 -2.80
Vical Incorporated (VICL.OQ) $1.42 -0.45

Earnings vs. Estimates